// Publications

// Select publication year: 2003
43. Flow Monitoring: Performance Characteristics of Ultrasound Dilution Versus Color Doppler Ultrasound Compared With Fistulography. Am J Kidney Dis 2003, 42:539-545. (IF 9.4)

Schwarz C, Mitterbauer C, Boczula M, Maca T, Funovics M, Heinze G, Lorenz M, Kovarik J, Oberbauer R.

42. Long-term improvement in renal function is shown in patients treated with sirolimus and cyclosporine withdrawal: 2-year results of the rapamune maintenance regimen. Transplantation 2003, 76:364-370. (IF 5.3)

Oberbauer et al.

41. Health related quality of life outcomes of sirolimus treated kideny transplant patients after elimination of cyclosporine: results of a two-year randomized clinical trial. Transplantation 2003, 75:1277-1285. (IF 5.3)

Oberbauer R et al.

40. Impaired tubulointerstitial expression of ET-1 and NOS isoforms in donor kidney biopsies with postischemic acute renal failure. Transplantation 2003, 76:715-720. (IF 5.3)

Mitterbauer C, Schwarz C, Hauser P, Steininger R, Regele HM, Rosenkranz A, Oberbauer R.

39. Body mass index is the main risk factor for arterial hypertension in young subjects without major comorbidity. Europ J Clin Invest 2003, 33:223-230. (IF 4.4)

Lukas A, Kumbein F, Temml C, Mayer B, Oberbauer R.

38. The influence of comorbidity on the effect of levofloxacin treatment success of ambulatory respiratory tract infections. WMW 2003, 7/8:156-162. (IF 1.1)

Burgmann H, Mayer B, Lukas A, Kumbein F, Oberbauer R.

37. Zoledronic acid to prevent bone loss in the first six months after renal transplantation. Kidney Int 2003, 63:1130-1136. (IF 14.8)

Haas M, Leko-Mohr Z, Roschger P, Kletzmayr J, Schwarz C, Mitterbauer C, Steininger R, Grampp S, Klaushofer K, Delling G, Oberbauer R.

SCIENTIFIC COLLABORATIONS